Hasegawa J, Wada Y, Sageshima M, Suzuki M, Kamiyama S, Abe N, Koizumi A
Department of Anesthesiology, Akita University School of Medicine, Japan.
Pharmacol Toxicol. 1990 May;66(5):367-72. doi: 10.1111/j.1600-0773.1990.tb00764.x.
The structure-pulmonary toxicity relationship was investigated using three different O,O,S-trimethylphosphorothioate (OOS-TMP) analogues, which is known to induce a typical mortality pattern (delayed death) and pulmonary injury; O,O-dimethyl S-ethyl (OOS-DMEP), O,O-dimethyl S-propyl (OOS-DMPP), and O,O-dimethyl S-butyl (OOS-DMBP) phosphorothioates. The mortality pattern in rats dosed with OOS-DMEP was similar to the "delayed death" pattern: the LD50s in rats for OOS-DMEP decreased dramatically from more than 200 mg/kg within 24 hr to 41.1 (males) or 13.8 (females) mg/kg 7 days after treatment while the LD50s in rats for OOS-DMPP and OOS-DMBP did not. Histopathological examinations revealed that OOS-DMEP induced pulmonary oedema and bleeding at a dose of 1/2 LD50 by 72 hr after dosing while the other two compounds did not. Thus, it was concluded that OOS-DMEP induces pulmonary injury, thereby eliciting the "delayed death" mortality pattern.
使用三种不同的O,O,S-三甲基硫代磷酸酯(OOS-TMP)类似物研究了结构与肺毒性之间的关系,已知该类似物会引发典型的死亡模式(延迟死亡)和肺损伤;O,O-二甲基S-乙基(OOS-DMEP)、O,O-二甲基S-丙基(OOS-DMPP)和O,O-二甲基S-丁基(OOS-DMBP)硫代磷酸酯。用OOS-DMEP给药的大鼠的死亡模式与“延迟死亡”模式相似:OOS-DMEP在大鼠中的半数致死剂量(LD50)在24小时内从超过200毫克/千克急剧下降到治疗7天后的41.1(雄性)或13.8(雌性)毫克/千克,而OOS-DMPP和OOS-DMBP在大鼠中的LD50则没有。组织病理学检查显示,OOS-DMEP在给药72小时后以1/2 LD50的剂量诱导肺水肿和出血,而其他两种化合物则没有。因此,得出结论,OOS-DMEP会诱导肺损伤,从而引发“延迟死亡”的死亡模式。